Sujal Shah
CIK: 0001588861
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 9, 2026TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
6K shares- - Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
12K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10.4K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | TVRD Tvardi Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 6,000 | - | - | Direct |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 12,000 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 10,394 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 8,047 | - | - | Direct |
1-4 of 4 transactions
About Shah Sujal
Shah Sujal (SEC CIK 0001588861) files insider reports with the SEC as Director of Tvardi Therapeutics, Inc. (TVRD).
Signal8 holds 4 ownership filings by Shah Sujal (1 Form 3, 3 Form 4), filed between Apr 17, 2025 and Jun 11, 2026. Those filings report 4 transactions, from Apr 15, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shah Sujal's filings is in SUGAR LAND, TX.
Recent filings by Shah Sujal
Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)
- Shiff Susan Ph.D., Director
- Smith Cynthia, Director
- HALL WALLACE L JR, Director
- WYZGA MICHAEL S, Director
- O'Brien Stephen Paul, Principal Accounting Officer
- Conn Avi Daniel, Chief Financial Officer